KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) EPS (Weighted Average and Diluted) (2016 - 2026)

Staar Surgical (STAA) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with -$0.36 as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 47.83% year-over-year to -$0.36, compared with a TTM value of -$1.62 through Jan 2026, down 295.12%, and an annual FY2026 reading of -$1.62, down 295.12% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.36 for Q1 2026 at Staar Surgical, down from $0.18 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.26 in Q3 2022 and bottomed at -$1.1 in Q1 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.05, with a median of $0.12 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 100.0% in 2024, then tumbled 1471.43% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.13 in 2022, then rose by 23.08% to $0.16 in 2023, then plummeted by 531.25% to -$0.69 in 2024, then skyrocketed by 126.09% to $0.18 in 2025, then tumbled by 300.0% to -$0.36 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for STAA at -$0.36 in Q1 2026, $0.18 in Q3 2025, and -$0.34 in Q2 2025.